Vimta Labs Limited (NSE:VIMTALABS)
India
· Delayed Price · Currency is INR | Market Cap | 20.93B |
| Revenue (ttm) | 3.45B |
| Net Income (ttm) | 667.55M |
| Shares Out | n/a |
| EPS (ttm) | 29.60 |
| PE Ratio | 31.35 |
| Forward PE | n/a |
| Dividend | 2.00 (0.21%) |
| Ex-Dividend Date | May 30, 2025 |
| Volume | 73,259 |
| Average Volume | 105,673 |
| Open | 954.95 |
| Previous Close | 945.50 |
| Day's Range | 936.65 - 957.60 |
| 52-Week Range | 472.05 - 1,178.00 |
| Beta | -0.13 |
| RSI | 41.22 |
| Earnings Date | May 13, 2025 |
About Vimta Labs
Vimta Labs Limited provides contract research and testing services in India and internationally. The company offers drug discovery, development, and drug life cycle management support services in the areas of preclinical research, clinical research, and analytical services for biopharmaceutical companies; preclinical research and testing services for medical device companies; and contract research and testing for agrochemical and specialty chemical companies. It also provides food testing and analytical development services to support manufactu... [Read more]
Financial Performance
In 2024, Vimta Labs's revenue was 3.45 billion, an increase of 19.25% compared to the previous year's 2.90 billion. Earnings were 667.55 million, an increase of 36.76%.
Financial StatementsNews
Stocks to watch on April 29: Wipro, UCO Bank, Central Bank of India, Go Digit, Avenue Supermarts, Oberoi Realty, Ultratech, Vimta Labs, RBL Bank
The Indian stock market is likely to react to a host of corporate earnings, operational updates, and sector developments on Monday, April 29. Companies such as UCO Bank, Central Bank of India, Go Digi...
Vimta Labs Q4 FY25 profit rises 31% YoY; announces 1:1 bonus issue and new biologics R&D foray
Vimta Labs Limited reported robust financial results for the fourth quarter and financial year ended March 31, 2025, backed by strong growth in its pharmaceutical services business. Financial highligh...
Vimta Labs shares surge 34% in past one month
Vimta Labs has been a standout performer in the stock market, with its shares surging 34% over the past month. The stock hit a 52-week high of ₹980.75 on December 6, 2024, reflecting strong investor i...